BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27081032)

  • 1. Colorectal cancer cell-derived extracellular vesicles induce phenotypic alteration of T cells into tumor-growth supporting cells with transforming growth factor-β1-mediated suppression.
    Yamada N; Kuranaga Y; Kumazaki M; Shinohara H; Taniguchi K; Akao Y
    Oncotarget; 2016 May; 7(19):27033-43. PubMed ID: 27081032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen inhibits the growth of colon cancer in mice through reversing extracellular vesicle-mediated immunosuppressive tumor microenvironment.
    Jiang L; Fei H; Yang A; Zhu J; Sun J; Liu X; Xu W; Yang J; Zhang S
    Cancer Lett; 2021 Nov; 520():332-343. PubMed ID: 34391809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-Secreted Extracellular Vesicles Regulate T-Cell Costimulation and Can Be Manipulated To Induce Tumor-Specific T-Cell Responses.
    Zhao X; Yuan C; Wangmo D; Subramanian S
    Gastroenterology; 2021 Aug; 161(2):560-574.e11. PubMed ID: 33895168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1 in tumor microenvironments induces immunosuppression in the tumors and sentinel lymph nodes and promotes tumor progression.
    Nakamura S; Yaguchi T; Kawamura N; Kobayashi A; Sakurai T; Higuchi H; Takaishi H; Hibi T; Kawakami Y
    J Immunother; 2014; 37(2):63-72. PubMed ID: 24509168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor Potential of Extracellular Vesicles Released by Genetically Modified Murine Colon Carcinoma Cells With Overexpression of Interleukin-12 and shRNA for TGF-β1.
    Rossowska J; Anger N; Wegierek K; Szczygieł A; Mierzejewska J; Milczarek M; Szermer-Olearnik B; Pajtasz-Piasecka E
    Front Immunol; 2019; 10():211. PubMed ID: 30814999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated Polarization of Tumor-Associated Macrophages by miR-145 via Colorectal Cancer-Derived Extracellular Vesicles.
    Shinohara H; Kuranaga Y; Kumazaki M; Sugito N; Yoshikawa Y; Takai T; Taniguchi K; Ito Y; Akao Y
    J Immunol; 2017 Aug; 199(4):1505-1515. PubMed ID: 28696255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis.
    Zhou X; Mao Y; Zhu J; Meng F; Chen Q; Tao L; Li R; Fu F; Liu C; Hu Y; Wang W; Zhang H; Hua D; Chen W; Zhang X
    Oncotarget; 2016 Oct; 7(41):67196-67211. PubMed ID: 27626488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8α
    Wan S; Wang S; Weng L; Zhang G; Lin Z; Fei X; Zhang F; Yang F; Wang J; Cai Z
    J Immunol; 2018 Mar; 200(5):1651-1660. PubMed ID: 29358274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors.
    Szvicsek Z; Oszvald Á; Szabó L; Sándor GO; Kelemen A; Soós AÁ; Pálóczi K; Harsányi L; Tölgyes T; Dede K; Bursics A; Buzás EI; Zeöld A; Wiener Z
    Cell Mol Life Sci; 2019 Jun; 76(12):2463-2476. PubMed ID: 31028424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of circulating extracellular vesicles with altered expression and function during pregnancy.
    Nardi Fda S; Michelon TF; Neumann J; Manvailer LF; Wagner B; Horn PA; Bicalho Mda G; Rebmann V
    Immunobiology; 2016 Jul; 221(7):753-60. PubMed ID: 27005781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin Mediated Activation of PI3K/Akt Signalling Pathway Modifies the Proteomic Cargo of Extracellular Vesicles.
    Liem M; Ang CS; Mathivanan S
    Proteomics; 2017 Dec; 17(23-24):. PubMed ID: 28842968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFBR2‑dependent alterations of microRNA profiles in extracellular vesicles and parental colorectal cancer cells.
    Fricke F; Mussack V; Buschmann D; Hausser I; Pfaffl MW; Kopitz J; Gebert J
    Int J Oncol; 2019 Oct; 55(4):925-937. PubMed ID: 31432155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2.
    Clayton A; Mitchell JP; Court J; Mason MD; Tabi Z
    Cancer Res; 2007 Aug; 67(15):7458-66. PubMed ID: 17671216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
    Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
    Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of LAP
    Zhong W; Jiang ZY; Zhang L; Huang JH; Wang SJ; Liao C; Cai B; Chen LS; Zhang S; Guo Y; Cao YF; Gao F
    World J Gastroenterol; 2017 Jan; 23(3):455-463. PubMed ID: 28210081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-Type OATP1B3 mRNA in Extracellular Vesicles as a Promising Candidate for a Serum-Based Colorectal Cancer Biomarker.
    Morio H; Sun Y; Harada M; Ide H; Shimozato O; Zhou X; Higashi K; Yuki R; Yamaguchi N; Hofbauer JP; Guttmann-Gruber C; Anzai N; Akita H; Chiba K; Furihata T
    Biol Pharm Bull; 2018; 41(3):445-449. PubMed ID: 29491222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of intratumoral regulatory T cells by human gastric cancer cells is dependent on transforming growth factor-β1.
    Lu X; Liu J; Li H; Li W; Wang X; Ma J; Tong Q; Wu K; Wang G
    J Surg Oncol; 2011 Nov; 104(6):571-7. PubMed ID: 21695703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway.
    Wang X; Liu C; Wang J; Fan Y; Wang Z; Wang Y
    Oncol Rep; 2017 Feb; 37(2):747-753. PubMed ID: 27959430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.